Literature DB >> 17460224

Challenges in using observational studies to evaluate adverse effects of treatment.

Michael D Hughes1, Paige L Williams.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17460224     DOI： 10.1056/NEJMp078038

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Development of appropriate coronary heart disease risk prediction models in HIV-infected patients.

Authors:  Morris Schambelan; Peter W F Wilson; Kevin E Yarasheski; W Todd Cade; Victor G Dávila-Román; Ralph B D'Agostino; Tarek A Helmy; Matthew Law; Kristin E Mondy; Sharon Nachman; Linda R Peterson; Signe W Worm
Journal:  Circulation       Date:  2008-06-19       Impact factor: 29.690

2.  No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.

Authors:  Heather J Ribaudo; Constance A Benson; Yu Zheng; Susan L Koletar; Ann C Collier; Judith J Lok; Marlene Smurzynski; Ronald J Bosch; Barbara Bastow; Jeffrey T Schouten
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

3.  Postmarketing Research and Surveillance: Issues and Challenges.

Authors:  David B Resnik
Journal:  Monitor (Assoc Clin Pharmacol)       Date:  2008-04

Review 4.  A pathway to improved prospective observational post-authorization safety studies.

Authors:  Victor A Kiri
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

5.  Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Authors:  Paige L Williams; Miguel Marino; Kathleen Malee; Susan Brogly; Michael D Hughes; Lynne M Mofenson
Journal:  Pediatrics       Date:  2010-01-18       Impact factor: 7.124

6.  Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

Authors:  Michael J Mugavero; Margaret May; Ross Harris; Michael S Saag; Dominique Costagliola; Matthias Egger; Andrew Phillips; Huldrych F Günthard; Francois Dabis; Robert Hogg; Frank de Wolf; Gerd Fatkenheuer; M John Gill; Amy Justice; Antonella D'Arminio Monforte; Fiona Lampe; Jose M Miró; Schlomo Staszewski; Jonathan A C Sterne
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

7.  Cardiac risk: not so simple.

Authors:  Judith A Aberg; Heather Ribaudo
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226

Review 8.  Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.

Authors:  Su Golder; Yoon K Loke; Martin Bland
Journal:  PLoS Med       Date:  2011-05-03       Impact factor: 11.069

9.  Beyond post-marketing research and MedWatch: Long-term studies of drug risks.

Authors:  David B Resnik
Journal:  Drug Des Devel Ther       Date:  2007-10-01       Impact factor: 4.162

10.  Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.

Authors:  Stacie B Dusetzina; Christina D Mack; Til Stürmer
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.